Bmj British Medical Journal
News
Covid vaccine: Prioritise over 16s living with immunosuppressed adults, says JCVI
BMJ 2021; 372 doi: https://doi.org/10.1136/bmj.n852 (Published 29 March 2021)
Cite this as: BMJ 2021;372:n852
Rapid response
Re: Covid vaccine: Prioritise over 16s living with immunosuppressed adults, says JCVI
Dear Editor
COVID-19 immunization in India
Till 01.04.2021 India has vaccinated around 68.7 (68,789,138) million people above the age of 45 years of age with COVID-19 vaccination . It is better to immunize people above the age of 16 years with immunocompromised state.
In India third dose of Covaxin gets nod for trials, six months after second dose.
Competing interests: No competing interests
02 April 2021
M.A. Aleem
Emeritus Professor of Neurology * Visiting Specialist in Neurology ** Consultant Neurologist ***
The Tamilnadu Dr.M.G.R. Medical University * Dhanalakshami Srinivasan Medical College ** ABC Hospital ***
Chennai 600032* Perambalure 621212** Trichy 620018*** Tamilnadu India
@drmaaleem
شركة تنظيف فلل بالرياض
ReplyDeleteشركة جلي بلاط بالرياض
شركة مكافحة حشرات بمكة
شركة كشف تسربات بمكة